Weekly Insider Report: Biotech and Medical Stocks
The BHI Weekly Insider Report is posted on BHI once a week, usually on Sunday or Monday. BHI does not take any responsibility for any financial loss or damage caused by or related to the following reports. BHI does not guarantee the accuracy of the reports. The following information should be used for entertainment purposes only.
This week's report:
BIOTECH
bought Kosan Biosciences (KOSN): Oct 31, $3.99-$4 by Officer
bought GTC Biother (GTCB): NOv 6, $1.05-$1.07 by Officer
bought Nektar Ther (NKTR): Nov 7, $14.65 by Officer
sold Pharm Prod Dev (PPDI): Nov 2, $29.55-$30.42 by Officer
sold Cytyc (CYTC): Nov 6-8, $26.53-$26.99 by 3 Officers
sold Amgen (AMGN): Nov 7, $75.23-$75.47 by Officer
sold Applera (ABI): Nov 3-7, $37.15-$38.45 by Officer
sold Regeneron (REGN): Nov 6-8, $22.25-$24.75 by 3 Officers
sold Cambrex (CBM): Nov 2-6, $22.58-$22.95 by 3 Officers
sold Digene (DIGE): Nov 6-7, $49-$50 by 5 Officers & Director
sold Amylin Pharm (AMLN): Nov 3-7, $43.40-$45by 2 Officers & Director
sold Acorda Ther (ACOR): Nov 6-7, $14.88-$16.22 by 4 Officers
DRUGS
bought Cytomedix (GTF): Nov 6-7, $1.06-$1.14 by Officer & Director
bought Pain Ther (PTIE): Nov 9, $8.03 by Beneficial Owner
sold Sciele Pharm (SCRX): Nov 2-8, $20.50-$21.46 by Officer & Director
sold Pfizer (PFE): Nov 6, $26.91 by Officer
sold United Ther (UTHR): Nov 2-3, $58.70-$59.67 by 3 officers & Director
sold Pain Ther (PTIE): Nov 6, $8.28 by Officer
sold Pozen (POZN): NOv 1-6, $15.70-$16.39 by Officer & Director
sold Conor Medsys (CONR): Nov 3, $25.00 by Officer
sold KOS Pharm (KOSP): Nov 6, $76.95 by Officer
sold Xenoport (XNPT): Nov 6, $23.87-$23.94 by Director
sold Vanda Pharm (VNDA): Nov 6-8, $11-$11.90 by 2 Officers & Beneficial Owner
MEDICAL SUPPLIES
bought Electro-optical (MELA): Nov 3, $5.68 by Director
bought Boston Scientific (BSX): Nov 2, $16.03 by Director
bought Signalife (SGN): Nov 1-2, $1.61-$1.64 by Director
sold Stryker (SYK): Nov 2-7, $51.88-$52.39 by Beneficial Owner
sold Becton Dickinson (BDX): Nov 3-6, $70.62-$72.01 by 3 Officers
sold Dentsply (XRAY): Nov 6, $30.95-$31.15 by Officer
sold Arrow Int (ARRO): Nov 2-8, $34.53-$35.57 by Director
sold Kinetic Concepts (KCI): Nov 6-8, $33.80-$34.12 by Director
sold West Pharm (WST): Nov 6-7, $45.99-$47.20 by 3 Officers & Director
sold Biosite (BSTE): Nov 3, $45.48-$45.81 by Officer
sold Intuitive Surgical (ISRG): Nov 7-9, $96.50-$99.30 by 3 Directors
sold Sonic Innovations (SNCI): Nov 7, $4.70-$4.73 by Director
_
The BHI Weekly Insider Report is posted on BHI once a week, usually on Sunday or Monday. BHI does not take any responsibility for any financial loss or damage caused by or related to the following reports. BHI does not guarantee the accuracy of the reports. The following information should be used for entertainment purposes only.
This week's report:
BIOTECH
bought Kosan Biosciences (KOSN): Oct 31, $3.99-$4 by Officer
bought GTC Biother (GTCB): NOv 6, $1.05-$1.07 by Officer
bought Nektar Ther (NKTR): Nov 7, $14.65 by Officer
sold Pharm Prod Dev (PPDI): Nov 2, $29.55-$30.42 by Officer
sold Cytyc (CYTC): Nov 6-8, $26.53-$26.99 by 3 Officers
sold Amgen (AMGN): Nov 7, $75.23-$75.47 by Officer
sold Applera (ABI): Nov 3-7, $37.15-$38.45 by Officer
sold Regeneron (REGN): Nov 6-8, $22.25-$24.75 by 3 Officers
sold Cambrex (CBM): Nov 2-6, $22.58-$22.95 by 3 Officers
sold Digene (DIGE): Nov 6-7, $49-$50 by 5 Officers & Director
sold Amylin Pharm (AMLN): Nov 3-7, $43.40-$45by 2 Officers & Director
sold Acorda Ther (ACOR): Nov 6-7, $14.88-$16.22 by 4 Officers
DRUGS
bought Cytomedix (GTF): Nov 6-7, $1.06-$1.14 by Officer & Director
bought Pain Ther (PTIE): Nov 9, $8.03 by Beneficial Owner
sold Sciele Pharm (SCRX): Nov 2-8, $20.50-$21.46 by Officer & Director
sold Pfizer (PFE): Nov 6, $26.91 by Officer
sold United Ther (UTHR): Nov 2-3, $58.70-$59.67 by 3 officers & Director
sold Pain Ther (PTIE): Nov 6, $8.28 by Officer
sold Pozen (POZN): NOv 1-6, $15.70-$16.39 by Officer & Director
sold Conor Medsys (CONR): Nov 3, $25.00 by Officer
sold KOS Pharm (KOSP): Nov 6, $76.95 by Officer
sold Xenoport (XNPT): Nov 6, $23.87-$23.94 by Director
sold Vanda Pharm (VNDA): Nov 6-8, $11-$11.90 by 2 Officers & Beneficial Owner
MEDICAL SUPPLIES
bought Electro-optical (MELA): Nov 3, $5.68 by Director
bought Boston Scientific (BSX): Nov 2, $16.03 by Director
bought Signalife (SGN): Nov 1-2, $1.61-$1.64 by Director
sold Stryker (SYK): Nov 2-7, $51.88-$52.39 by Beneficial Owner
sold Becton Dickinson (BDX): Nov 3-6, $70.62-$72.01 by 3 Officers
sold Dentsply (XRAY): Nov 6, $30.95-$31.15 by Officer
sold Arrow Int (ARRO): Nov 2-8, $34.53-$35.57 by Director
sold Kinetic Concepts (KCI): Nov 6-8, $33.80-$34.12 by Director
sold West Pharm (WST): Nov 6-7, $45.99-$47.20 by 3 Officers & Director
sold Biosite (BSTE): Nov 3, $45.48-$45.81 by Officer
sold Intuitive Surgical (ISRG): Nov 7-9, $96.50-$99.30 by 3 Directors
sold Sonic Innovations (SNCI): Nov 7, $4.70-$4.73 by Director
_
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home